As of 2024-09-09, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 0.72 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 5.64 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -87.2%.
The range of the Relative Valuation is (0.55) - 1.43 CAD.
| Range | Selected | |
| Trailing P/E multiples | 2.6x - 4.0x | 3.3x |
| Forward P/E multiples | -13.5x - -6.8x | -10.2x |
| Fair Price | (0.55) - 1.43 | 0.72 |
| Upside | -109.8% - -74.6% | -87.2% |
| Date | P/E |
| 2024-09-06 | -26.84 |
| 2024-09-05 | -26.75 |
| 2024-09-04 | -26.75 |
| 2024-09-03 | -26.08 |
| 2024-08-30 | -26.13 |
| 2024-08-29 | -26.17 |
| 2024-08-28 | -26.32 |
| 2024-08-27 | -26.51 |
| 2024-08-26 | -26.98 |
| 2024-08-23 | -26.98 |
| 2024-08-22 | -27.17 |
| 2024-08-21 | -27.56 |
| 2024-08-20 | -27.32 |
| 2024-08-19 | -27.51 |
| 2024-08-16 | -27.36 |
| 2024-08-15 | -27.08 |
| 2024-08-14 | -26.98 |
| 2024-08-13 | -27.32 |
| 2024-08-12 | -26.75 |
| 2024-08-09 | -27.70 |
| 2024-08-08 | -27.41 |
| 2024-08-07 | -26.37 |
| 2024-08-06 | -26.41 |
| 2024-08-02 | -26.41 |
| 2024-08-01 | -26.98 |
| 2024-07-31 | -27.22 |
| 2024-07-30 | -26.51 |
| 2024-07-29 | -26.75 |
| 2024-07-26 | -27.17 |
| 2024-07-25 | -27.03 |
| 2024-07-24 | -26.60 |
| 2024-07-23 | -27.08 |
| 2024-07-22 | -27.13 |
| 2024-07-19 | -27.27 |
| 2024-07-18 | -27.17 |
| 2024-07-17 | -27.32 |
| 2024-07-16 | -27.56 |
| 2024-07-15 | -27.89 |
| 2024-07-12 | -27.22 |
| 2024-07-11 | -27.41 |
| 2024-07-10 | -26.84 |
| 2024-07-09 | -26.56 |
| 2024-07-08 | -27.22 |
| 2024-07-05 | -27.08 |
| 2024-07-04 | -27.08 |
| 2024-07-03 | -27.36 |
| 2024-07-02 | -27.22 |
| 2024-06-28 | -26.98 |
| 2024-06-27 | -26.65 |
| 2024-06-26 | -26.08 |